Search Type: drug or dietary supplement name
Search Term: allopurinol (LOPURIN, ZYLOPRIM)


Worst Pills, Best Pills Newsletter Articles

Worst Pills, Best Pills Newsletter Articles

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a secondary subject of discussion
  • News Brief: Dangerous Gout Medication Withdrawn from Market [hide all summaries]
    (April 2019)
    In this month’s news brief, we report on Ironwood Pharmaceuticals’ recent decision to cease marketing its dangerous gout drug lesinurad (ZURAMPIC, DUZALLO). Several years ago, we had designated the drug as Do Not Use because its substantial risks far outweighed its benefits.
  • Gout Drug Febuxostat (ULORIC): Risks Outweigh Benefits [hide all summaries]
    (May 2018)
    When the FDA approved febuxostat in 2009 for treating high uric acid blood levels in patients with gout, we advised readers not to use the drug until at least February 2016 based on our longstanding “Seven-Year Rule.” Read this article to hear results of new research that prompted us to now designate febuxostat as Do Not Use.

SHOW primary search results for allopurinol (LOPURIN, ZYLOPRIM)